Journal article · 2016
Nanoparticles engineered for antigen-specific immunotherapy
Nature Reviews Drug Discovery, 15(4), 233 · Published 1 April 2016 · DOI 10.1038/nrd.2016.62
In brief
“Nanoparticles engineered for antigen-specific immunotherapy” is a 2016 journal article by Alexandra Flemming, published in Nature Reviews Drug Discovery. OpenAlex counts 7 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 7
- Most cited in
- 2025 (2)
- Field-weighted impact
- 0.14
- References
- 1
- Authors
- 1
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Flemming, A. (2016). Nanoparticles engineered for antigen-specific immunotherapy. Nature Reviews Drug Discovery, 15(4), 233. https://doi.org/10.1038/nrd.2016.62
MLA 9
Flemming, Alexandra. “Nanoparticles engineered for antigen-specific immunotherapy.” Nature Reviews Drug Discovery, vol. 15, no. 4, 2016, p. 233. https://doi.org/10.1038/nrd.2016.62.
Chicago
Flemming, Alexandra. 2016. “Nanoparticles engineered for antigen-specific immunotherapy.” Nature Reviews Drug Discovery 15 (4): 233. https://doi.org/10.1038/nrd.2016.62.
Harvard
Flemming, A. (2016) ‘Nanoparticles engineered for antigen-specific immunotherapy’, Nature Reviews Drug Discovery, 15(4), p. 233. doi:10.1038/nrd.2016.62.
IEEE
A. Flemming, “Nanoparticles engineered for antigen-specific immunotherapy,” Nature Reviews Drug Discovery, vol. 15, no. 4, p. 233, 2016, doi: 10.1038/nrd.2016.62.
BibTeX
@article{flemming2016nanoparticles,
title = {{Nanoparticles engineered for antigen-specific immunotherapy}},
author = {Flemming, Alexandra},
journal = {Nature Reviews Drug Discovery},
year = {2016},
volume = {15},
number = {4},
pages = {233},
doi = {10.1038/nrd.2016.62},
url = {https://doi.org/10.1038/nrd.2016.62}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 1 | |
| 2020 | 1 | |
| 2022 | 1 | |
| 2025 | 2 | |
| 2026 | 2 |
Its field-weighted citation impact is 0.14: it has been cited 0.14 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- nanoparticles
- antigen-specific immunotherapy
- autoimmunity
- regulatory T cells
- regulatory networks
- nanoparticle drug delivery
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Flemming, A. (2016). Nanoparticles engineered for antigen-specific immunotherapy. Nature Reviews Drug Discovery, 15(4), 233. https://doi.org/10.1038/nrd.2016.62
How many times has this paper been cited?
7 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Alexandra Flemming.
What is the DOI of this paper?
10.1038/nrd.2016.62, permanently at https://doi.org/10.1038/nrd.2016.62. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.